-The Hindu There are now as many as 9,000 Indian medical students in China As the costs of a medical education in India continue to rise, an increasing number of students are heading to foreign shores, with China, in particular, emerging as a favoured destination. A six year-education at an approved Chinese medical university, consultants say, can cost Rs. 25 lakh, including one-year internship and annual travel to India, although costs vary at...
More »SEARCH RESULT
Too early to die
-The Hindu It cannot get any worse than this. Over three lakh newborns in India die on the very first day of their birth. With this the country ranks as number one in terms of first day of birth mortality; its share in global first-day deaths stands at 29 per cent. The appalling state of Indian health care to which this speaks is further highlighted by the fact that the...
More »Stuck record: Why Amartya Sen is wrong on food security again -R Jagannathan
-Firstpost.com It is becoming increasingly difficult to retain respect for Nobel laureate Amartya Sen. He seems to surface in the media every time the UPA government is about to legislate its pet follies, providing intellectual succour to mindless spending and corruption wrapped up in the package of anti-poverty schemes. Yesterday, Sen bobbed up just when the UPA - under siege for every known scam in India - tried to start discussions on...
More »Aadhaar to help eradicate poverty, says World Bank chief Jim Yong Kim
-PTI WASHINGTON: Describing Aadhaar card as one of the best example of integration of technology for social welfare use, the World Bank President, Jim Yong Kim, believes that this massive effort by the Indian Government would help in achieving his goal of poverty eradication by 2030. "On a larger scale we've got to think about how we can integrate this technology into a massive effort to scale up access to financial...
More »Strong Medicine for poor countries-Nayanima Basu
-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...
More »